Close Menu

NEW YORK (GenomeWeb) – N-of-One said today that it has raised $7 million in a Series B financing round from Providence Ventures and Excel Venture Management.

N-of-One said it plans to use the funds to expand its efforts to develop precision medicine-based clinical decision support solutions that provide physicians with a precise and scalable approach for matching patients to treatments and clinical trials. The proceeds will also be used to expand sales and marketing efforts in the US and other strategic global markets, the company said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Atlantic reports another SARS-CoV-2 testing problem may be lurking: backlogs.

The US Biomedical Advanced Research and Development Authority is supporting efforts to develop vaccines against SARS-CoV-2.

Researchers have sequenced the genome of "the Methuselah of freshwater fish."

In Genome Biology this week: difference in methylation in neurons from Parkinson's disease patients, differential expression analysis by barcoded sequencing approach, and more.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.